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INTRODUCTION 
Twenty years ago, President Clinton signed the Health Insurance 
Portability and Accountability Act of 1996 (HIPAA) into law.1 Over the past 
two decades, the federal Department of Health and Human Services (HHS) has 
published several sets of rules2 implementing the Administrative 
Simplification provisions within HIPAA3 as well as the Health Information 
Technology for Economic and Clinical (HITECH) Act within the American 
Recovery and Reinvestment Act (ARRA).4 These rules include, but certainly 
are not limited to, a final rule published on January 25, 2013, governing the use 
and disclosure of protected health information by covered entities and their 
business associates (the Privacy Rule).5 
Since 2003, I have been teaching one-, two-, and three-credit Privacy Rule 
classes at law schools across the country. I also have provided continuing 
education and other training programs on the topic of the Privacy Rule to 
practicing physicians, dentists, clinical psychologists, social workers, nurses, 
and other health care professionals, as well as non-lawyer privacy officials and 
other health industry participants. My goal with this Article is to examine 
approaches to teaching the Privacy Rule to law and non-law audiences. 
Through trial and error, I believe I have improved my Privacy Rule teaching 
since 2003, and I wish to share my pedagogical successes and failures in this 
Article. 
This Article proceeds as follows: Part I summarizes the history of the 
Privacy Rule, including the many proposed rules, interim final rules, final 
rules, guidance documents, and resolution agreements published by HHS.6 Part 
II reviews the Privacy Rule’s theory of and approach to health information 
confidentiality.7 Part III discusses my experience teaching the Privacy Rule to 
both law and non-law audiences.8 
In part because few judicial opinions interpreting the Privacy Rule are 
substantively helpful, Part III argues that Privacy Rule teachers may wish to 
 
 1. Health Insurance Portability and Accountability Act of 1996, Pub. L. No. 104-191, 110 
Stat. 1936 [hereinafter HIPAA]. 
 2. See infra notes 18–33 (referencing several sets of proposed, interim final, and final 
rules). 
 3. HIPAA, Title II, Subtitle F, §§ 261–264 [hereinafter Administrative Simplification 
Provisions]. 
 4. See American Recovery and Reinvestment Act of 2009, Pub. L. No. 111-5, § 13001–
13424, 123 Stat. 115, 226–279 [hereinafter ARRA] (including the Health Information 
Technology for Economic and Clinical Health (HITECH) Act). 
 5. Privacy of Individually Identifiable Health Information, 45 C.F.R. §§ 164.500–164.534, 
Part 164, Subpart E (2016) [hereinafter Privacy Rule]. 
 6. Infra Part I. 
 7. Infra Part II. 
 8. Infra Part III. 
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teach fewer cases and focus instead on the principles of health information 
confidentiality gleaned from the preambles to HHS’s rulemakings as well as 
HHS’s guidance documents, resolution agreements, and frequently-asked 
questions.9 Part III further suggests that Privacy Rule teachers who train non-
law audiences solicit questions in advance and use these questions to illustrate 
the Privacy Rule’s use-and-disclosure requirements, as bird’s-eye legal 
overviews tend to be unhelpful.10 
I.  HISTORY OF THE PRIVACY RULE11 
As signed into law by President Clinton on August 21, 1996, HIPAA had 
several purposes, including improving portability and continuity of health 
insurance coverage in the individual and group markets, combating health care 
fraud and abuse, promoting the use of medical savings accounts, improving 
access to long-term care services and insurance coverage, and simplifying the 
administration of health insurance.12 The Administrative Simplification 
Provisions, codified at Subtitle F of Title II of HIPAA,13 directed HHS to issue 
regulations protecting the privacy14 of individually identifiable health 
 
 9. Infra Part III. 
 10. Infra Part III. 
 11. I have reviewed the history of and the regulatory approach taken in the Privacy Rule in a 
number of prior scholarly articles. See, e.g., Stacey A. Tovino, Hospital Chaplaincy Under the 
HIPAA Privacy Rule: Health Care or “Just Visiting the Sick?”, 2 IND. HEALTH L. REV. 51 
(2005); STACEY A. TOVINO, Medical Privacy, in GOVERNING AMERICA: MAJOR DECISIONS OF 
FEDERAL, STATE, AND LOCAL GOVERNMENTS FROM 1789 TO THE PRESENT 644 (Paul J. Quirk & 
William Cunion eds. 2011); Stacey A. Tovino, HIPAA Privacy for Physicians, 17 PATHOLOGY 
CASE REV. 160 (2012); Stacey A. Tovino, Gone Too Far: Federal Regulation of Health Care 
Attorneys, 91 OR. L. REV. 813 (2013); Stacey A. Tovino, Silence Is Golden . . . Except in Health 
Care Philanthropy, 48 U. RICH. L. REV. 1157 (2014); Stacey A. Tovino, Complying with the 
HIPAA Privacy Rule: Problems and Perspectives, 1 LOYOLA U. CHI. J. REG. COMPLIANCE 23 
(2016). With technical and conforming changes, much of Parts I and II of this Article are 
reprinted from these prior scholarly articles with my permission. 
 12. See HIPAA, Pub. L. No. 104-191, Preface, 110 Stat. 1936, 1936 (“An Act [t]o amend the 
Internal Revenue Code of 1986 to improve portability and continuity of health insurance coverage 
in the group and individual markets, to combat waste, fraud, and abuse in health insurance and 
health care delivery, to promote the use of medical savings accounts, to improve access to long-
term care services and coverage, to simplify the administration of health insurance, and for other 
purposes.”). 
 13. See Administrative Simplification Provisions, supra note 3. 
 14. Elsewhere, I defined and distinguished the concepts of privacy and confidentiality for 
purposes of discussions addressing the legal responsibilities of health industry participants. See, 
e.g., Stacey A. Tovino, Functional Neuroimaging Information: A Case for Neuro 
Exceptionalism?, 34 FLA. ST. U. L. REV. 415, at Parts III(J), IV, and V (2007). This Article uses 
the same definitions and distinctions. Privacy refers to an individual’s interest in avoiding the 
unwanted collection by a third party of health or other information about the individual. Id. at 
442. Confidentiality, on the other hand, refers to the obligation of a health industry participant to 
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information if Congress failed to enact comprehensive privacy legislation 
within three years of HIPAA’s enactment.15 When Congress failed to enact 
privacy legislation by its deadline, HHS incurred the duty to adopt privacy 
regulations.16 The original HIPAA statute clarified, however, that any privacy 
regulations adopted by HHS must be made applicable only to three classes of 
individuals and institutions: (1) health plans; (2) health care clearinghouses; 
and (3) health care providers who transmit health information in electronic 
form in connection with certain standard transactions (collectively, covered 
entities).17 
HHS responded. On November 3, 1999,18 and December 28, 2000,19 HHS 
issued a proposed and final privacy rule regulating covered entities’ uses and 
disclosures of protected health information (PHI). On March 27, 2002,20 and 
August 14, 2002,21 HHS issued proposed and final modifications to the 
Privacy Rule. With the exception of technical corrections and conforming 
 
prevent the unauthorized or otherwise inappropriate use or disclosure of voluntarily given and 
appropriately gathered health and other information relating to an individual. Id. Although the 
Privacy Rule actually is a health information confidentiality rule—because it sets limits on how 
health care providers and other covered entities can use and disclose appropriately gathered 
PHI—I use the phrase “Privacy Rule” and the word “privacy” in this Article because these are the 
phrases and words selected by HHS and used by the public for the rule and the concepts 
addressed therein. See, e.g., The HIPAA Privacy Rule, U.S. DEP’T HEALTH & HUMAN SERVS., 
https://www.hhs.gov/hipaa/for-professionals/privacy/ [https://perma.cc/XNM4-TFRM]. 
 15. See Administrative Simplification Provisions, supra note 3, at § 264 (“If legislation 
governing standards with respect to the privacy of individually identifiable health information . . . 
is not enacted by the date that is 36 months after the date of the enactment of this Act, the 
Secretary of Health and Human Services shall promulgate final regulations containing such 
standards . . . .”). 
 16. See id. 
 17. § 262(a) (“Any standard adopted under this part shall apply, in whole or in part, to the 
following persons: (1) A health plan. (2) A health care clearinghouse. (3) A health care provider 
who transmits any health information in electronic form in connection with a transaction referred 
to in section 1173(a)(1).”). See generally Standards for Privacy of Individually Identifiable Health 
Information, 64 Fed. Reg. 59,918, 59,924 (proposed Nov. 3, 1999) [hereinafter 1999 Proposed 
Rule] (explaining that HHS did not directly regulate any entity that was not a covered entity 
because it did not have the statutory authority to do so). 
 18. 1999 Proposed Rule, supra note 17, at 59,918. 
 19. Standards for Privacy of Individually Identifiable Health Information, 65 Fed. Reg. 
82,462 (Dec. 28, 2000) (codified at 45 C.F.R. pt. 160–164) [hereinafter 2000 Final Rule]. 
 20. Standards for Privacy of Individually Identifiable Health Information, 67 Fed. Reg. 
14,776 (Mar. 27, 2002) (codified at 45 C.F.R. pt. 160–164). 
 21. Standards for Privacy of Individually Identifiable Health Information, 67 Fed. Reg. 
53,182 (Aug. 14, 2002) (codified at 45 C.F.R. pt. 160–164) [hereinafter 2002 Final 
Modifications]. 
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amendments,22 these rules as reconciled remained largely unchanged between 
2002 and 2009. 
The nature and scope of the legal duties of confidentiality that applied to 
covered entities and their business associates (BAs)23 changed significantly 
more than eight years ago. On February 17, 2009, President Obama signed 
ARRA into law.24 Division A, Title XIII of ARRA, better known as HITECH, 
contained certain provisions requiring HHS to modify some of the information 
use and disclosure requirements and definitions set forth in the Privacy Rule, 
adopt new breach notification rules, and amend the civil penalty amounts that 
may be imposed on covered entities and BAs who violate the Privacy Rule.25 
Since ARRA’s enactment, HHS has issued several sets of proposed rules, 
interim final rules, final rules, and technical corrections both implementing 
HITECH’s required changes to the Privacy Rule as well as responding to other 
national health information confidentiality concerns. On August 24, 2009, for 
example, HHS released an interim final rule implementing HITECH’s new 
breach notification requirements.26 On October 30, 2009, HHS released an 
interim final rule implementing HITECH’s strengthened enforcement 
provisions, including strengthened civil monetary penalties that the federal 
 
 22. See, e.g., Standards for Privacy of Individually Identifiable Health Information, 
Correction of Effective and Compliance Dates, 66 Fed. Reg. 12,434 (Feb. 26, 2001) (codified at 
45 C.F.R. pt. 160–164); Technical Corrections to the Standards for Privacy of Individually 
Identifiable Health Information Published December 28, 2000, 65 Fed. Reg. 82,944 (Dec. 29, 
2000) (codified at 45 C.F.R. pt. 160–164) [hereinafter Technical Corrections I]. 
 23. Business associates (BAs) are defined to include individual and institutions who: (1) on 
behalf of a covered entity, but other than in the capacity of a member of the workforce of a 
covered entity, create, receive, maintain, or transmit PHI for a function or activity regulated by 
the HIPAA Privacy Rule; and (2) provide, other than in the capacity of a member of the 
workforce of such covered entity, legal, actuarial, accounting, consulting, data aggregation, 
management, administrative, accreditation, or financial services to or for the covered entity. See 
Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules 
under the Health Information Technology for Economic and Clinical Health Act and the Genetic 
Information Nondiscrimination Act; Other Modifications to the HIPAA Rules, 78 Fed. Reg. 
5566, 5688 (Jan. 25, 2013) (codified at 45 C.F.R. 160 and 164) (adopting 45 C.F.R. § 160.103 
and providing a new definition of business associate) [hereinafter Final Regulations]. 
 24. ARRA, supra note 4. 
 25. Id. Elsewhere, I critiqued HITECH’s imposition of confidentiality requirements directly 
on BAs and proposed statutory and regulatory changes to HITECH and the HIPAA Privacy Rule, 
respectively, that would except a class of BAs, including outside counsel, from the confidentiality 
obligations imposed on other BAs. See Stacey A. Tovino, Gone Too Far: Federal Regulation of 
Health Care Attorneys, 91 OR. L. REV. 813 (2013). Elsewhere, I also critiqued HITECH’s 
loosening of the regulatory provision that governs covered entities’ uses and disclosures of 
protected health information for fundraising purposes. See Stacey A. Tovino, Silence Is 
Golden . . . Except in Health Care Philanthropy, 48 U. RICH. L. REV. 1157 (2014). This Article 
builds on my earlier scholarship focusing on the Privacy Rule. 
 26. Breach Notification for Unsecured Protected Health Information, 74 Fed. Reg. 42,740 
(Aug. 24, 2009) (codified at 45 C.F.R. pt. 160–164). 
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Office for Civil Rights (OCR) may, for the first time since the enactment of the 
HIPAA statute, impose directly on BAs who fail to maintain the confidentiality 
of PHI.27 On May 31, 2011, HHS released a proposed rule that would modify 
the HIPAA Privacy Rule’s accounting of disclosures requirement.28 On 
January 25, 2013, HHS released a final rule modifying the HIPAA Privacy, 
Security, Breach Notification, and Enforcement Rules in accordance with 
HITECH (Final Regulations).29 On June 7, 2013, HHS released technical 
corrections to the Final Regulations.30 On September 16, 2013, HHS released a 
Model Notice of Privacy Practices designed to assist covered entities in 
complying with the Final Regulations.31 On February 6, 2014, HHS released a 
final rule modifying the Privacy Rule to provide individuals with a right to 
receive their laboratory test results directly from their testing laboratories.32 On 
January 6, 2016, HHS released a final rule modifying the Privacy Rule to 
permit certain covered entities to disclose protected health information to the 
National Instant Criminal Background Check System such as the identities of 
individuals who are disqualified from shipping, transporting, possessing, or 
receiving a firearm.33 And, as of this writing, HHS is working on a notice of 
proposed rulemaking (NPRM) that would allow civil money penalties and 
settlements associated with Privacy Rule violations to be shared with harmed 
individuals, as required by HITECH.34 
In addition to its proposed, interim final, and final rulemakings, HHS also 
has made publicly available forty different resolution agreements. In these 
agreements, covered entities resolve to comply with the Privacy Rule, report to 
HHS regarding its compliance with the Privacy Rule, and/or pay a resolution 
 
 27. HIPAA Administrative Simplification: Enforcement, 74 Fed. Reg. 56,123 (Oct. 30, 
2009) (codified at 45 C.F.R. pt. 160). 
 28. HIPAA Privacy Accounting of Disclosures under the Health Information Technology for 
Economic and Clinical Health Act, 76 Fed. Reg. 31,426 (May 31, 2011) (codified at 45 C.F.R. pt. 
164). 
 29. Final Regulations, supra note 23. 
 30. See Technical Corrections to the HIPAA Privacy, Security, and Enforcement Rules, 78 
Fed. Reg. 32,464, 32,466 (June 7, 2013) (to be codified at 45 C.F.R. pt. 160–164) [hereinafter 
Technical Corrections II]. 
 31. Model Notices of Privacy Practices, U.S. DEP’T HEALTH & HUMAN SERVS., 
http://www.hhs.gov/hipaa/for-professionals/privacy/guidance/model-notices-privacy-practices/ 
[https://perma.cc/57PE-8958] [hereinafter Model Notice]. 
 32. CLIA Program and HIPAA Privacy Rule; Patients’ Access to Test Reports, 79 Fed. Reg. 
7290 (Feb. 6, 2014) (codified at 45 C.F.R. pt. 164). 
 33. Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule and the 
National Instant Criminal Background Check System (NICS), 81 Fed. Reg. 382 (Jan. 6, 2016) (to 
be codified at 45 C.F.R. pt. 164). 
 34. E-mail from Iliana Peters, U.S. Dep’t Health & Human Servs., to Stacey Tovino, 
University of Nevada, Las Vegas (Sept. 26, 2016, 4:23 A.M. PT) (on file with author). 
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amount.35 In a recent resolution agreement released by HHS on September 23, 
2016, HHS required Care New England Health System (CNE)—on behalf of 
eight current covered entities that are under CNE’s common ownership or 
control, including Woman & Infants Hospital of Rhode Island (WIH)—to pay 
HHS $400,000 and complete a comprehensive correction active plan following 
WIH’s loss of two unencrypted backup tapes containing electronic PHI.36 In a 
second recent resolution agreement, executed by HHS and New York 
Presbyterian Hospital (Hospital) on April 19, 2016, HHS required the Hospital 
to pay $2.2 million and complete a comprehensive corrective action plan 
following the Hospital’s impermissible disclosure of protected health 
information to the media as part of a reality television show, and the Hospital’s 
failure to implement privacy-related safeguards.37 
II.  THE PRIVACY RULE’S APPROACH TO HEALTH INFORMATION 
CONFIDENTIALITY 
A brief summary of the Privacy Rule’s theory and approach to health 
information confidentiality is necessary before discussing how best to teach the 
Privacy Rule to law and non-law audiences. The Privacy Rule strives to 
balance the interest of individuals in maintaining the confidentiality of their 
health information and the interest of society in obtaining, using, and 
disclosing health information to carry out a variety of public and private 
activities.38 To this end, the Privacy Rule regulates covered entities’ and BAs’ 
uses of, disclosures of, and requests for individually identifiable health 
information (IIHI)39 to the extent such information does not constitute: (1) an 
 
 35. Resolution Agreements, U.S. DEP’T HEALTH & HUMAN SERVS., https://www.hhs.gov/hi 
paa/for-professionals/compliance-enforcement/agreements/index.html [https://perma.cc/4TJ8-H7 
7G]. 
 36. See Resolution Agreement between U.S. Dep’t Health & Human Servs. and Care New 
England Health Sys. (Sept. 23, 2016), http://www.hhs.gov/sites/default/files/9-14-16-wih-racap-
1.pdf [https://perma.cc/4KC5-2WRZ]. 
 37. See Resolution Agreement between U.S. Dep’t Health & Human Servs. and New York 
Presbyterian Hosp. (Apr. 19, 2016), http://www.hhs.gov/sites/default/files/NYP%20NYMed%20 
RACAP%20April%202016%20%28508%29_0.pdf [https://perma.cc/V9FE-YV7R] [hereinafter 
New York Presbyterian Hospital Resolution Agreement]. 
 38. See 2000 Final Rule, supra note 19, at 82,464 (“The rule seeks to balance the needs of 
the individual with the needs of the society.”); id. at 82,468 (“The task of society and its 
government is to create a balance in which the individual’s needs and rights are balanced against 
the needs and rights of society as a whole.”); id. at 82,472 (“The need to balance these competing 
interests—the necessity of protecting privacy and the public interest in using identifiable health 
information for vital public and private purposes—in a way that is also workable for the varied 
stakeholders causes much of the complexity in the rule.”). 
 39. The Privacy Rule defines individually identifiable health information (IIHI) as 
[I]information that is a subset of health information, including demographic information 
collected from an individual, and: (1) Is created or received by a health care provider, 
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education record protected under the Family Educational Rights and Privacy 
Act of 1974 (FERPA); (2) a student treatment record excepted from protection 
under FERPA; (3) an employment record held by a covered entity in its role as 
an employer; or (4) individually identifiable health information regarding a 
person who has been deceased for more than fifty years.40 The name given by 
the Privacy Rule to the subset of IIHI described in the previous sentence is 
protected health information (PHI).41 
Before using or disclosing PHI, the Privacy Rule requires covered entities 
and BAs to adhere to one of three different rules—sometimes called the use-
and-disclosure rules—depending on the purpose of the information use or 
disclosure.42 These rules reflect HHS’s desire to appropriately balance the 
interest of individuals in maintaining the confidentiality of their PHI with a 
wide range of societal interests in obtaining, using, or disclosing PHI, some of 
which may have greater societal importance and value than others.43 
The first rule allows covered entities and BAs to use and disclose PHI with 
no prior permission from the individual who is the subject of the PHI—but 
only in certain situations. That is, covered entities may freely use and disclose 
PHI without any form of prior permission in order to carry out their own 
treatment,44 payment,45 and health care operations46 activities,47 as well as 
certain public benefit activities.48 
 
health plan, employer, or health care clearinghouse; and (2) Relates to the past, present, or 
future physical or mental health or condition of an individual; the provision of health care 
to an individual; or the past, present, or future payment for the provision of health care to 
an individual; and (i) That identifies the individual; or (ii) With respect to which there is a 
reasonable basis to believe the information can be used to identify the individual. 
45 C.F.R. § 160.103 (2016). 
 40. Id. (defining “protected health information”). 
 41. Id. (using the phrase “protected health information”). 
 42. §§ 164.502–164.514 (setting forth the use and disclosure requirements applicable to 
covered entities and business associates). 
 43. See 2000 Final Rule, supra note 19, at 82,464 (“The rule seeks to balance the needs of 
the individual with the needs of the society.”); id. at 82,468 (“The task of society and its 
government is to create a balance in which the individual’s needs and rights are balanced against 
the needs and rights of society as a whole.”); id. at 82,472 (“The need to balance these competing 
interests—the necessity of protecting privacy and the public interest in using identifiable health 
information for vital public and private purposes—in a way that is also workable for the varied 
stakeholders causes much of the complexity in the rule.”). 
 44. The Privacy Rule defines treatment as: 
[T]he provision, coordination, or management of health care and related services by one 
or more health care providers, including the coordination or management of health care by 
a health care provider with a third party; consultation between health care providers 
relating to a patient; or the referral of a patient for health care from one health care 
provider to another. 
45 C.F.R. § 164.501 (2016). 
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As an example of this first rule, a covered general practitioner (GP) who 
wishes to consult with a specialist in order to treat a patient may disclose PHI 
to the specialist and the Privacy Rule does not require the patient to give the 
GP prior authorization for the disclosure.49 Likewise, a covered hospital that 
treats a patient may send a bill to the patient’s insurer to obtain payment for 
hospital services rendered without the patient’s prior authorization.50 Similarly, 
a teaching physician employed by a covered academic medical center may 
involve medical students, interns, residents, and fellows in patient care, 
without prior authorization from the patients who are receiving such care, to 
enable the students and residents to learn to practice medicine.51 By still 
further example, a covered entity that is required by state or other law to 
disclose PHI to another individual or entity may do so without patient 
authorization.52 By final illustrative example, a covered entity may disclose a 
patient’s PHI to a law enforcement officer in certain situations, including when 
the covered entity suspects that the death of the patient may have resulted from 
criminal conduct.53 The theory behind these permitted information uses and 
disclosures is that treating patients, allowing health care providers to obtain 
 
 45. The Privacy Rule defines payment as the activities “undertaken by a health plan to 
obtain premiums or to determine or fulfill its responsibility for coverage and provision of benefits 
under the health plan” as well as the activities of a “health care provider or health plan to obtain 
or provide reimbursement for the provision of health care.” Id. 
 46. The Privacy Rule defines health care operations with respect to a list of activities that are 
related to a covered entity’s covered functions. Id. (defining “health care operations”). These 
activities include, but are not limited to, conducting quality assessment and improvement 
activities, conducting training programs in which medical and other health care students learn to 
practice health care under supervision, and arranging for the provision of legal services. See id. 
 47. § 164.506(c)(1) (permitting a covered entity to use or disclose PHI for its own treatment, 
payment, or health care operations). 
 48. Covered entities may use and disclose PHI for twelve different public policy activities 
without the prior written authorization of the individual who is the subject of the information. § 
164.512(a)–(l). These public policy activities include, but are not limited to, uses and disclosures 
required by law, uses and disclosures for public health activities, disclosures for law enforcement 
activities, uses and disclosures for research, and disclosures for workers’ compensation activities. 
See § 164.512(a), (c), (f), (i), (l) (2016). 
 49. § 164.501 (defining “treatment” to include “consultations between health care providers 
relating to a patient”). 
 50. See id. (defining “payment” to include “the activities undertaken by a health care 
provider . . . to obtain . . . reimbursement for the provision of health care”); § 164.506(c)(1) 
(permitting a covered entity to disclose PHI for its own payment activities). 
 51. Id. (defining “health care operations” to include “conducting training programs in which 
students, trainees, or practitioners in areas of health care learn under supervision to practice or 
improve their skills as health care providers.”). 
 52. See § 164.512(a) (allowing covered entities to “use or disclose protected health 
information to the extent that such use or disclosure is required by law and the use or disclosure 
complies with and is limited to the relevant requirements of such law.”). 
 53. § 164.512(f)(4). 
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reimbursement for providing health care, training medical students and 
residents, complying with state law, and alerting law enforcement officers to 
the suspicion of criminal activity outweigh an individual’s interest in 
maintaining complete confidentiality of his or her PHI. 
The first rule requires no prior authorization from the individual who is the 
subject of the information before the information use or disclosure may occur. 
Under the second rule, a covered entity may use and disclose an individual’s 
PHI for certain activities, but only if the individual is informed in advance of 
the use or disclosure and has the opportunity to agree to or prohibit or restrict 
the use or disclosure.54 Because the Privacy Rule allows the covered entity to 
orally inform the individual of (and capture an oral agreement or oral objection 
to) a use or disclosure permitted by these provisions, this second rule is 
sometimes referred to as the “oral permission rule,” although a more practical 
written permission also will suffice. 
Under the second rule, a covered entity may conduct five sets of 
information uses and disclosures once the individual who is the subject of the 
information has been notified and has either agreed or not objected to the 
information use or disclosure.55 These five sets of information uses and 
disclosures include: (1) certain uses and disclosures of directory information, 
such as name, location, general condition, and religious affiliation;56 (2) certain 
uses and disclosures that would allow other persons to be involved in a 
patient’s care or payment for care;57 (3) certain uses and disclosures that would 
help notify, or assist in the notification of, family members, personal 
representatives, and other persons responsible for the care of the individual of 
the individual’s location, general condition, or death;58 (4) certain uses and 
disclosures for disaster relief purposes;59 and (5) certain disclosures to family 
members and other persons who were involved in the individual’s care or 
payment for health care prior to the individual’s death of PHI that is relevant to 
that person’s involvement.60 
As an illustration of the second rule, the hospital room number and general 
condition of a patient (e.g., ‘good,’ ‘fair,’ ‘poor,’ ‘stable’) who has given his or 
her permission or who has not expressed an objection may be disclosed to a 
visitor who requests directory information about that patient.61 Likewise, a 
woman in labor who wishes her partner to be present for her labor and delivery 
 
 54. § 164.510. 
 55. Id. 
 56. § 164.510(a). 
 57. § 164.510(b)(1)(i). 
 58. § 164.510(b)(1)(ii). 
 59. § 164.510(b)(4). 
 60. § 164.510(b)(5). 
 61. § 164.510(a)(1), (2). 
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may orally give her permission for her health care providers to involve her 
partner in her care.62 
The theory behind requiring at least oral permission for these information 
uses and disclosures is that the patient has an interest in maintaining the 
confidentiality of his or her PHI; however, the patient also may have an 
interest in being visited in the hospital, in obtaining assistance with the 
patient’s health care or payment for health care, and being assisted during a 
disaster. In addition, the patient’s family also may have an interest in visiting 
the patient in the hospital, assisting the patient with his or her health care and 
financial needs, and obtaining assistance during a disaster. The required oral 
permission reflects the individual’s interest in maintaining the confidentiality 
of his or her health information but the lack of a requirement for a formal 
written authorization reflects HHS’s desire to make it easy for the individual to 
ask for or agree to receive help. 
The third rule—a default rule—requires covered entities and BAs to obtain 
the prior written authorization of the individual who is the subject of the PHI 
before using or disclosing the individual’s PHI in any situation that does not fit 
under the first or second rule. Stated another way, in the event that a covered 
entity or BA would like to use or disclose PHI for a purpose that is not 
treatment, payment, or health care operations, that does not fall within one of 
twelve public benefit exceptions, that is not allowed with oral permission or 
without an objection, and that is not otherwise permitted or required by the 
Privacy Rule, the covered entity must obtain the prior written authorization of 
the individual who is the subject of the information.63 
The Privacy Rule specifies the form of the authorization required by the 
third rule, including certain elements and statements that are designed to place 
the individual on notice of how the individual’s PHI will be used or 
disclosed.64 This high level of prior individual permission reflects the value 
HHS places on an individual’s interest in maintaining the confidentiality of his 
or her PHI compared to other societal interests that are far removed from the 
core functions of covered entities and BAs, such as a health care provider’s 
interest in selling the patient’s information to a tabloid magazine or a health 
plan’s interest in disclosing the patient’s information to a marketing company 
to allow the company to market its products and services to the individual.65 
 
 62. § 164.510(b)(1)(i). 
 63. § 164.508(a)(1). 
 64. § 164.508(c)(1)–(2). 
 65. See 2000 Final Rule, supra note 19, at 82,514 (“[C]overed entities must obtain the 
individual’s authorization before using or disclosing protected health information for marketing 
purposes.”). 
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With this background regarding the Privacy Rule’s theory and approach to 
health information confidentiality, Part III of this Article will discuss methods 
of teaching the Privacy Rule to law and non-law audiences. 
III.  TEACHING THE PRIVACY RULE 
A. Teaching the Case Law 
Since Fall 2003, I have taught a number of law courses based heavily in 
the common law, including Torts. When teaching Torts, I focus almost 
exclusively on the hundreds of cases made available by the authors of my 
assigned casebook.66 I think these cases are outstanding for helping students 
understand the intentional torts, negligence, strict liability, products liability, 
and other tort-based theories of liability, as well as their privileges and 
defenses. Occasionally, I will supplement these cases with a Restatement 
provision or a Nevada statute (since I teach at the University of Nevada, Las 
Vegas), especially if the provision or statute is relevant to an issue under 
discussion. For example, if I am discussing a case in which a plaintiff sues a 
defendant for one tort but not a second tort because the statute of limitations 
has already run on the second tort, I may ask the students to look up the 
Nevada statute that sets forth the statute of limitations for the second tort.67 
The vast majority of my Torts class discussions, however, focus on theories of 
liability as well as privileges and defenses to the torts as they are presented in 
federal and state judicial opinions. 
When I first started teaching the Privacy Rule in Fall 2003, I was 
uncomfortable because I was forced to teach straight from the final rule that 
was published in the Federal Register on December 28, 2000,68 as well as the 
final modifications published in the Federal Register on August 14, 2002.69 
Because most covered entities did not have to comply with the Privacy Rule 
until April 14, 2003,70 there were few published cases, other than statutory and 
regulatory challenges, before then.71 Even after April 14, 2003, it took cases 
 
 66. See VICTOR E. SCHWARTZ, KATHRYN KELLY & DAVID F. PARTLETT, PROSSER, WADE, 
AND SCHWARTZ’S TORTS: CASES AND MATERIALS (13th ed. 2015). 
 67. NEV. REV. STAT. § 41A.097(2) (2016) (“[A]n action for injury or death against a 
provider of health care may not be commenced more than 3 years after the date of injury or 1 year 
after the plaintiff discovers or through the use of reasonable diligence should have discovered the 
injury, whichever occurs first, for . . . professional negligence . . . .”). 
 68. See 2000 Final Rule, supra note 19, at 82,462. 
 69. Standards for Privacy of Individually Identifiable Health Information, 67 Fed. Reg. 
53,182 (Aug. 14, 2002) (codified at 45 C.F.R. pt. 160–164). 
 70. See 45 C.F.R. § 164.534(a), (b)(1) (2016) (establishing an April 14, 2003 compliance 
date for covered health care providers and non-small health plans). 
 71. See, e.g., S.C. Med. Ass’n v. Thompson, 327 F.3d 346, 351–55 (4th Cir. 2003) 
(declaratory judgment action challenging HIPAA; holding that HIPAA did not impermissibly 
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involving federal health information confidentiality issues a while to work 
their way through the courts and to be published as judicial opinions. In 
addition, because the Privacy Rule contains no private right of action, many of 
the early judicial opinions simply clarified the lack of such right and dismissed 
the plaintiffs’ claims on that basis.72 Few substantively helpful judicial 
opinions assessing the use-and-disclosure requirements codified at 45 C.F.R. 
§§ 164.502–514, the individual rights provisions codified at 45 C.F.R. §§ 
164.520–528, the breach notification requirements codified at 45 C.F.R. §§ 
164.400–410, and the administrative requirements codified at 45 C.F.R. § 
164.530 were available in the early 2000s for use in class discussions. 
As courts began publishing opinions addressing substantive HIPAA 
Privacy issues, I placed them in my syllabus in the appropriate place. Some of 
these judicial opinions were helpful in clarifying issues that the Privacy Rule 
itself did not answer. 
For example, remember that the first use-and-disclosure rule discussed in 
Part II allows covered entities and BAs to use and disclose PHI for their own 
treatment, payment, and health care operations (TPO) activities without any 
form of prior permission from the individual who is the subject of the PHI.73 
The regulation that allows these uses and disclosures74 is frequently referred to 
as the “TPO rule.” Although the Privacy Rule defines the terms treatment, 
payment, and health care operations,75 these definitions do not answer every 
single “Is this TPO?” question I receive from my students. 
One illustrative question I have received more than once is whether 
coerced, sometimes called assisted, treatment received by an individual who is 
 
delegate legislative function, the Privacy Rule was not beyond scope of congressional grant of 
authority, and that neither HIPAA nor the Privacy Rule was impermissibly vague); Ass’n Am. 
Physicians & Surgeons, Inc. v. U.S. Dep’t Health & Human Servs., 224 F. Supp. 2d 1115, 1118, 
1126–27 (S.D. Tex. 2002) (declaratory judgment action against HHS challenging the Privacy 
Rule as beyond the legislative scope of HIPAA as unconstitutional; holding in part that the 
Privacy Rule was within the scope of HIPAA). 
 72. See, e.g., Univ. of Colo. Hosp. Auth. v. Denver Publ’g Co., 340 F. Supp. 2d 1142, 1146 
(D. Colo. 2004) (“Because I find no such statutory intent in HIPAA, I may not imply a private 
right of action, and University Hospital’s claim under HIPAA should be dismissed.”); Agee v. 
United States, 72 Fed. Cl. 284, 289–90 (Ct. Cl. 2006) (“Accordingly, this Court dismisses 
Plaintiff’s claims concerning violations of HIPAA because the statute does not provide for a 
private right of action against the Federal Government.”); Johnson v. Quander, 370 F. Supp. 2d 
79, 100 (D.D.C. 2005) (“Here, the plaintiff challenges, pursuant to the HIPAA, the disclosure of 
information regarding his DNA . . . [B]ecause no private right of action exists under the HIPAA, 
this Court does not have subject matter jurisdiction over this claim and it must be dismissed.”). 
 73. 45 C.F.R. § 164.506(c)(1) (2016). See generally supra Part II (discussing the Privacy 
Rule’s requirements relating to uses and disclosures of protected health information). 
 74. See § 164.506(c)(1). 
 75. See § 164.501 (2016) (defining “treatment,” “payment,” and “operations” for purposes 
of the Privacy Rule). 
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involuntarily committed under state law falls within the Privacy Rule’s 
definition of treatment. If so, a covered entity, such as a covered hospital or 
clinic, would be permitted to disclose medical records supporting the severity 
of the individual’s mental health condition to a court that would be ruling on 
the involuntary commitment or a subsequent involuntary health care provider. 
The Privacy Rule does not address this issue.76 
However, in In re Miguel M., the New York Court of Appeals77 held that 
the purpose of the treatment rule is to facilitate the sharing of PHI among 
health care providers working together, not the sharing of PHI by one 
voluntary health care provider with a second, involuntary one.78 The court 
reasoned that, “[d]isclosure for that [involuntary] purpose is a more serious 
invasion of privacy than, for example, the transmission of medical records 
from a patient’s primary care physician to a specialist—the sort of activity for 
which the treatment exception seems primarily designed. The treatment 
exception is inapplicable here.”79 I have included In re Miguel M. in my 
Privacy Rule syllabus since its publication in 2011 because I can use it to 
illustrate a disclosure of PHI that implicates the TPO rule, to help my students 
understand the difference between voluntary and involuntary treatment, and to 
teach the limitations of the otherwise broad range of PHI uses and disclosures 
allowed under the TPO rule. 
In re Miguel M. is substantively helpful for other reasons as well. Because 
not all my HIPAA Privacy students have taken a course in Public Health Law 
before enrolling in HIPAA Privacy, they may not understand the difference 
between public health law, which focuses on legal measures that may help 
identify, prevent, and ameliorate health risks of a community,80 and private 
health law, which focuses on legal authorities that help guide disputes between 
individual physicians and patients, individual hospitals and particular medical 
staff members, and health plans and in-network or out-of-network providers, 
among other individual relationships. I have found that students who lack 
exposure to principles of public health law frequently are unable to apply the 
public health exception to the Privacy Rule, which allows covered entities to 
 
 76. See id. (defining “treatment” as the “provision, coordination, or management of health 
care and related services by one or more health care providers, including the coordination or 
management of health care by a health care provider with a third party; consultation between 
health care providers relating to a patient; or the referral of a patient for health care from one 
health care provider to another” but not clarifying whether the definition is limited to voluntary 
treatment or whether involuntary treatment is included). 
 77. In re Miguel M., 17 N.Y.3d 37 (N.Y. 2011). 
 78. Id. at 43. 
 79. Id. 
 80. See, e.g., Lawrence O. Gostin, A Theory and Definition of Public Health Law, 10 J. 
HEALTH CARE L. & POL’Y 1 (2007) (defining public health). 
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disclose PHI to public health authorities for public health purposes without the 
prior written authorization of the individuals who are the subject of the PHI.81 
In re Miguel M. is helpful for teaching students when the public health 
exception to the Privacy Rule applies. In In re Miguel M., the physician who 
was petitioning for Miguel’s involuntary commitment argued that the 
disclosure of Miguel’s PHI would protect the public health because it would 
help ensure that Miguel would be involuntarily committed and therefore would 
not injure or kill anyone else, including members of the public.82 The New 
York Court of Appeals disagreed, reasoning that the purpose of the public 
health exception was to “facilitate government activities that protect large 
numbers of people from epidemics, environmental hazards, and the like, or that 
advance public health by accumulating valuable statistical information.”83 The 
court found that the disclosure of PHI of one particular individual, such as 
Miguel M., for the purpose of preventing that individual from harming himself 
or others “effects a very substantial invasion of privacy without the sort of 
generalized public benefit that would come from, for example, tracing the 
course of an infectious disease.”84 The court ultimately ruled that the 
disclosure of Miguel’s PHI to the physician who was petitioning for Miguel’s 
involuntary commitment did not come within the scope of the public health 
exception. I love teaching this case because, in addition to the treatment 
analysis discussed above, it kills two more birds. That is, it teaches students the 
difference between public and private health and helps them identify situations 
when the public health exception to the Privacy Rule does and does not apply. 
Unlike In re Miguel M., however, many cases addressing Privacy Rule 
issues interpret the Rule incorrectly, in my opinion, or pass on ruling on 
Privacy Rule issues that the courts believe are too difficult to answer. For 
example, many courts struggle with the most basic of Privacy Rule issues, 
including determining whether a defendant is a covered entity to whom the 
Privacy Rule applies. In In re National Hockey League Players’ Concussion 
Injury Litigation, for example, the United States District Court for the District 
of Minnesota was set to analyze whether the National Hockey League (NHL) 
or any of its member teams were covered entities under the Privacy Rule.85 
 
 81. See 45 C.F.R. § 164.512(b)(1) (2016) (“A covered entity may . . . disclose protected 
health information . . . to . . . [a] public health authority that is authorized by law to collect or 
receive such information for the purpose of preventing or controlling disease, injury, or disability, 
including, but not limited to, the reporting of disease, injury, vital events such as birth or death, 
and the conduct of public health surveillance, public health investigations, and public health 
interventions . . . . ”). 
 82. In re Miguel M., 17 N.Y.3d at 42. 
 83. Id. at 42–43. 
 84. Id. at 43. 
 85. In re Nat’l Hockey League Players’ Concussion Injury Litig., 120 F. Supp. 3d 942, 953 
(D. Minn. 2015) (referencing the question of whether the NHL is a covered entity). 
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This analysis is simple and requires only asking the following: (1) Whether the 
teams meet the definition of a health plan by making health insurance available 
to their hockey players;86 or (2) Whether the teams meet the definition of a 
covered health care provider by making sports injury and other health care 
available to the hockey players and subsequently electronically billing a public 
or private health care program or plan for such care.87 
Instead of conducting this straightforward analysis, the court says: “It is 
unclear whether the [hockey teams] are covered entities.”88 I assigned this 
opinion, published on July 31, 2015, to my Spring 2016 HIPAA Privacy 
students because I thought the application of the Privacy Rule to a popular 
professional sports league would be interesting to my sports- and 
entertainment-obsessed law students. However, the court’s failure to rule on 
the issue in which my students were most interested—the question of whether 
NHL teams are covered entities—frustrated them. I will not include the 
opinion in future syllabi. 
B. Teaching the HHS Guidance 
In part because of the substantive weakness of much of the Privacy Rule 
case law, I focus my law-based teaching instead on HHS guidance. This 
guidance includes, but is certainly not limited to, preambles to all the proposed, 
interim final, and final rulemakings;89 separate, formal guidance documents 
released by HHS on various aspects of the Privacy Rule;90 hundreds of 
answers to frequently-asked questions made available by HHS;91 and dozens 
of resolution agreements entered into by HHS and a variety of covered 
entities.92 I have found the HHS Guidance tremendously helpful in teaching 
the Privacy Rule to law students. Allow me to provide a few examples of 
teaching strategies using several different types of HHS Guidance. 
The preambles to the proposed, interim final, and final rulemakings are 
gems for teaching. Members of the public ask questions about the application 
 
 86. 45 C.F.R. § 160.103 (2016) (defining health plan). 
 87. Id. (defining health care provider; defining covered entity). 
 88. In re Nat’l Hockey League, 120 F. Supp. 3d at 953. 
 89. See, e.g., supra notes 18–32 (referencing all the proposed, interim final, and final rules 
implementing section 264 of the HIPAA statute). 
 90. See Guidance on Significant Aspects of the Privacy Rule, U.S. DEP’T HEALTH & HUMAN 
SERVS., http://www.hhs.gov/hipaa/for-professionals/privacy/guidance/significant-aspects/in 
dex.html [https://perma.cc/TJN3-RGME] (providing guidance on seventeen different aspects of 
the Privacy Rule). 
 91. HIPAA FAQs for Professionals, U.S. DEP’T HEALTH & HUMAN SERVS., http://www.hhs. 
gov/hipaa/for-professionals/faq [https://perma.cc/XM2H-VKBM] (providing answers to hundreds 
of frequently-asked questions in dozens of categories). 
 92. Resolution Agreements, supra note 35 (listing resolution agreements entered into by and 
between HHS and covered entities starting in July 2008). 
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of the Privacy Rule that are very similar to the types of questions asked by law 
students, and HHS responds with its interpretation. I frequently assign my law 
students portions of the various preambles as reading and ask them questions 
in class based on HHS’s interpretations in these preambles. I do this for two 
reasons. First, the preambles nicely illustrate the notice-and-comment 
rulemaking process and allow the students to learn the procedure of 
administrative law while they are learning the substance of the Privacy Rule. 
Second, I want to encourage students to consult the preamble for HHS 
interpretations before issuing their own, unverified Privacy Rule interpretations 
to clients. As I will show using two examples below, HHS’s regulations are 
frequently unclear and the agency’s interpretations are not always expected. 
These two examples follow. 
First, the Privacy Rule allows covered health care providers to use and 
disclose PHI for their own treatment activities.93 The Privacy Rule defines a 
health care provider, in relevant part, as “any other person or organization who 
furnishes, bills, or is paid for health care in the normal course of business.”94 
The Privacy Rule further defines health care as: 
[C]are, services, or supplies . . . related to the health of the individual . . . 
[including but not limited to]: (1) Preventive, diagnostic, therapeutic, 
rehabilitative, maintenance, or palliative care; counseling; service; or 
procedure with respect to the physical or mental condition, or functional status, 
of an individual or that affects the structure or function of the body; and (2) 
Sale or dispensing of a drug, device, equipment, or other item in accordance 
with a prescription.95 
One question frequently asked by my students is whether a rabbi, priest, or 
other clergy person who provides religious or spiritual counseling or services 
at the hospital bedside is a health care provider, especially in the context of 
religious patients whose mental (and arguably physical) health depend on their 
faith. My students almost uniformly use their interpretive skills to answer this 
question in the affirmative based on the presence of the word counseling 
relative to a patient’s mental condition in the definition of health care and the 
fact that many hospitals employ hospital chaplains and expressly list these 
chaplains as members of the health care team on the hospitals’ websites.96 A 
quick search for the word “religious” in the preamble to the Privacy Rule 
reveals a different interpretation by HHS, however: 
 
 93. 45 C.F.R. § 164.506(c)(1) (2016). 
 94. § 160.103 (italicized emphasis added) (defining health care provider). 
 95. Id. (italicized emphasis added) (defining health care). 
 96. See, e.g., Your Healthcare Team, CONFLUENCE HEALTH, https://www.confluencehealth. 
org/patient-information/your-hospital-stay/healthcare-team/ [https://perma.cc/TFG9-UEWM] 
(including “chaplain” in the list of “[p]atient care team members”). 
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Also, in response to the comment regarding religious practitioners, the 
Department clarifies that “health care” as defined under the rule does not 
include methods of healing that are solely spiritual. Therefore, clergy or other 
religious practitioners that provide solely religious healing services are not 
health care providers within the meaning of this rule, and consequently not 
covered entities for the purposes of this rule.97 
If my students had relied on their interpretations (when in practice), they would 
have advised their clients incorrectly, perhaps encouraging a Privacy Rule 
violation. I use this example to encourage my students to always check the 
preamble for answers before relying on their own reasonable interpretations. I 
also use this example to show how quickly word searches can be conducted 
within the preamble to yield correct answers. 
A second example relates to the status of organ procurement organizations 
(OPOs) under the Privacy Rule. I used to represent a number of OPOs in a 
variety of civil, regulatory, and transactional matters. When the Privacy Rule’s 
April 14, 2003, compliance date neared, several of my OPO clients asked me 
whether they were covered health care providers that were required to comply 
with the Privacy Rule. Given that my OPO clients evaluated and procured 
deceased-donor organs for transplantation, a reasonable legal interpretation of 
the definition of health care provider98 might be that OPOs provide therapeutic 
services. In particular, they are responsible for matching organs to patients who 
need organs based on donor blood type, height, weight, and other medical 
factors, as well as proximity to the donor hospital,99 and helping make those 
organs available for transplantation. However, a quick search for the phrase 
“organ procurement organization” within the preamble reveals a different 
interpretation by HHS: 
Comment: Some commenters suggested that blood centers and plasma donor 
centers that collect and distribute source plasma not be considered covered 
health care providers because the centers do not provide “health care services” 
and the blood donors are not “patients” seeking health care. Similarly, 
commenters expressed concern that organ procurement organizations might be 
considered health care providers. 
Response: We agree and have deleted from the definition of “health care” the 
term “procurement or banking of blood, sperm, organs, or any other tissue for 
administration to patients.” 
I use this example, again, to encourage my students to check the preamble 
before relying on their own Privacy Rule interpretations. 
 
 97. See 2000 Final Rule, supra note 19, at 82,568. 
 98. See text accompanying supra note 94 (defining health care provider). 
 99. See, e.g., How Organs Are Matched, UNITED NETWORK FOR ORGAN SHARING, 
https://www.unos.org/transplantation/matching-organs/ [https://perma.cc/6SFW-XJ6Q] 
(describing the ways in which OPOs help facilitate organ transplantation). 
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A second source of HHS guidance is the formal guidance documents 
published by HHS on a wide variety of topics.100 These guidance documents 
are invaluable for teaching the tricky use-and-disclosure requirements to law 
students. The regulation codified at 45 C.F.R. § 164.506(c)(4) nicely illustrates 
this point. Although the Privacy Rule allows covered entities to freely use and 
disclose PHI to carry out their own TPO under 45 C.F.R. § 164.506(c)(1), the 
Privacy Rule strictly regulates covered entities’ disclosures of PHI to other 
individuals and institutions for the recipients’ health care operations (HCO) 
activities under 45 C.F.R. § 164.506(c)(4). Under this regulation, a covered 
entity may disclose PHI for another individual’s or entity’s HCO without the 
prior authorization of the individual who is the subject of the PHI, but only if 
four requirements have been satisfied: (1) the recipient individual or entity also 
is a covered entity; (2) both the sending and receiving covered entities have 
had in the past or have now a relationship with the individual who is the 
subject of the PHI to be disclosed; (3) the PHI to be disclosed pertains to that 
relationship; (4) the purpose of the disclosure is listed in the first or second 
paragraph of the definition of HCO101 or is a health care fraud and abuse 
detection or compliance activity.102 
Ensuring student comprehension of this regulation is difficult, in part 
because no judicial opinion provides an example of a disclosure that is, or is 
not, permitted by this regulation. However, HHS has released a guidance 
document titled “Uses and Disclosures for Treatment, Payment, and Health 
Care Operations” that provides an example of a permissible disclosure: “A 
health care provider may disclose protected health information to a health plan 
for the plan’s Health Plan Employer Data and Information Set (HEDIS) 
purposes, provided that the health plan has or had a relationship with the 
individual who is the subject of the information.”103 When students ask me to 
provide a clear example of a disclosure permitted by 45 C.F.R. § 
164.506(c)(4), I point them to this guidance document. After reading the 
 
 100. See supra note 90 (referencing the guidance documents published by HHS on a variety 
of Privacy Rule topics). 
 101. The definition of health care operations contains six long paragraphs, some of which 
have numerous clauses and/or sub-parts. See 45 C.F.R. § 164.501 (2016) (defining health care 
operations). The first and second paragraphs of the definition include activities relating to quality 
assessment and improvement, reviewing the competence or qualifications of health care 
professionals, licensing, certification, accreditation, training of health care professionals, and 
training of non-health care professionals. The third through sixth paragraph of the definition 
include activities such as underwriting, legal services, business planning and development, 
fundraising, and creating de-identified health information. See id. 
 102. 45 C.F.R. § 164.506(c)(4) (2016). 
 103. Uses and Disclosures for Treatment, Payment, and Health Care Operations, U.S. DEP’T 
HEALTH & HUMAN SERVS., http://www.hhs.gov/sites/default/files/ocr/privacy/hipaa/understand 
ing/coveredentities/sharingfortpo.pdf [https://perma.cc/6CU7-C4SP] (providing this example). 
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guidance document, the students typically report how helpful it is, especially 
because it provides other examples of PHI uses and disclosures that may (or 
may not) be made under all the different paragraphs within 45 C.F.R. § 
164.506. The students also report that this particular guidance document reads 
like an Examples and Explanations (E&E) resource,104 which they find helpful 
for studying first-year and Bar subjects. 
HHS’s formal guidance documents are helpful in other contexts as well. 
The Privacy Rule’s marketing provisions, for example, are quite complex, and 
my students frequently ask me to provide examples of communications that 
meet the definition of marketing and, for those that do, communications that 
require prior written authorization. As background, in one of the many sets of 
definitions within the Administrative Simplification Rules,105 HHS defines 
marketing as “a communication about a product or service that encourages 
recipients of the communication to purchase or use the product or service.”106 
However, HHS excepts from the definition of marketing communications that 
are made: 
(i) To provide refill reminders or otherwise communicate about a drug or 
biologic that is currently being prescribed for the individual, only if any 
financial remuneration received by the covered entity in exchange for making 
the communication is reasonably related to the covered entity’s cost of making 
the communication. (ii) For the following treatment and health care operations 
purposes, except where the covered entity receives financial remuneration in 
exchange for making the communication: (A) For treatment of an individual 
by a health care provider, including case management or care coordination for 
the individual, or to direct or recommend alternative treatments, therapies, 
health care providers, or settings of care to the individual; (B) To describe a 
health-related product or service (or payment for such product or service) that 
is provided by, or included in a plan of benefits of, the covered entity making 
the communication, including communications about: the entities participating 
in a health care provider network or health plan network; replacement of, or 
enhancements to, a health plan; and health-related products or services 
available only to a health plan enrollee that add value to, but are not part of, a 
plan of benefits; or (C) For case management or care coordination, contacting 
of individuals with information about treatment alternatives, and related 
 
 104. See Examples & Explanations, WOLTERS KLUWER, http://www.wklegaledu.com/series/ 
examples-explanations [https://perma.cc/P572-Z3N9] (providing information regarding the 
popular E&E series). 
 105. HHS codified definitions applicable to the Administrative Simplification Rules (Rules) 
in several different places throughout the Rules, including 45 C.F.R. §§ 160.103, 160.202, 
160.401, 160.502, 162.103, 164.103, 164.304, 164.402, 164.501 (2016). 
 106. See 45 C.F.R. § 164.501 (2016) (defining marketing). 
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functions to the extent these activities do not fall within the definition of 
treatment.107 
The Privacy Rule generally requires a covered entity to obtain an 
authorization from an individual before using or disclosing the individual’s 
PHI for an activity that falls within the definition of marketing. And, if the 
marketing activity involves financial remuneration, the Privacy Rule requires 
the written authorization form to identify such remuneration.108 However, the 
Privacy Rule does not require a covered entity to obtain an authorization from 
an individual before using or disclosing the individual’s PHI for marketing that 
takes the form of a “face-to-face communication made by a covered entity to 
an individual” or a “promotional gift of nominal value provided by the covered 
entity.”109 
Practicing health care attorneys have written volumes about the confusing 
nature of the Privacy Rule’s marketing provisions.110 If practicing health care 
attorneys struggle with the Privacy Rule’s marketing provisions, it is no 
surprise that my law students do as well. However, HHS released a guidance 
document devoted to marketing that walks students through each step of the 
analysis; that is, (1) whether a communication meets the definition of 
marketing or is excepted from the definition of marketing; and (2) for those 
that meet the definition of marketing, whether a prior written authorization is 
required or whether an exception to the authorization requirement exists.111 In 
addition to the straightforward two-step analysis, the guidance document also 
provides plenty of real-world examples of communications that do and do not 
fall within the definition of marketing as well as communications that do and 
 
 107. Id. 
 108. § 164.508(a)(3)(ii). 
 109. § 164.508(a)(3)(i). 
 110. See, e.g., Jay Hodes, The HIPAA Privacy Rule – What Is Often Confusing About Some of 
the Requirements?, LINKEDIN (Aug. 19, 2015), https://www.linkedin.com/pulse/hipaa-privacy-
rule-what-often-confusing-some-jay-hodes [https://perma.cc/83RK-TRNB] (“Another confusing 
area of the HIPAA Privacy Rule concerns marketing.”); Gerard Clum, HIPAA and the 
“Marketing” Quandary, DYNAMIC CHIROPRACTIC (Mar. 10, 2003), http://www.dynamicchiro 
practic.com/pdf_out/DynamicChiropractic.com-HIPAA-and-the-Marketing-Quandary-14868441 
79.pdf [https://perma.cc/6PXW-5UTN] (“One of the more confusing aspects of HIPAA involves 
the concept of ‘marketing,’ and your ability to use protected health information (PHI) for 
marketing purposes.”); Peter D. Ricoy, Marketing Under the HIPAA Megarule: The Rule 
Becomes Tighter, ABA HEALTH E-SOURCE (May 2013), http://www.americanbar.org/content/ 
newsletter/publications/aba_health_esource_home/aba_health_law_esource_1305_ricoy.html 
[https://perma.cc/EGH6-Y4PA] (“By design, using an individual’s protected health information 
(‘PHI’) for marketing purposes has never been easy under the HIPAA Privacy Rule.”). 
 111. Marketing, U.S. DEP’T HEALTH & HUMAN SERVS., 1, 1–4 (Apr. 3, 2003), http://www.hh 
s.gov/sites/default/files/ocr/privacy/hipaa/understanding/coveredentities/marketing.pdf 
[https://perma.cc/4GFU-97CY]. 
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do not require prior written authorization.112 My students have reported 
success in using HHS’s guidance on marketing to learn the Privacy Rule’s 
marketing provisions. 
In addition to the preamble language and the formal guidance documents, 
another source of helpful teaching material includes HHS’s answers to the 
hundreds of publicly-submitted, frequently-asked questions regarding the 
Privacy Rule.113 One question my students frequently ask me is whether 
contracted researchers who conduct research on behalf of a covered entity fall 
within the definition of a business associate of the covered entity due to the 
performance of such research. The question is a good one because the Privacy 
Rule defines a business associate to include persons who, with respect to a 
covered entity but other than in the capacity of a workforce member of the 
covered entity, “creates, receives, maintains, or transmits protected health 
information for a function or activity regulated by . . . [the Privacy Rule]”).114 
The Privacy Rule heavily regulates research at 45 C.F.R. § 164.512(i).115 A 
reasonable, logical interpretation of the definition of business associate, then, is 
that a contracted researcher who creates PHI while conducting research for the 
covered entity is a business associate of the covered entity. However, HHS’s 
answer to frequently-asked question number 239 provides a different 
interpretation: 
Question: Is a business associate contract required for a covered entity to 
disclose protected health information to a researcher? 
Answer: No. Disclosures from a covered entity to a researcher for research 
purposes do not require a business associate contract, even in those instances 
where the covered entity has hired the researcher to perform research on the 
covered entity’s own behalf. A business associate agreement is required only 
where a person or entity is conducting a function or activity regulated by the 
Administrative Simplification Rules on behalf of a covered entity, such as 
payment or health care operations, or providing one of the services listed in the 
definition of “business associate” at 45 CFR 160.103.116 
A final, illustrative source of outstanding teaching material includes the 
resolution agreements. HHS has entered into dozens of resolution agreements 
with covered entities pursuant to which a covered entity accused by HHS of 
violating the Privacy Rule agrees to perform certain obligations and make 
 
 112. Id. at 2–4. 
 113. HIPAA FAQs for Professionals, supra note 91. 
 114. 45 C.F.R. § 160.103 (2016) (emphasis added) (defining “business associate”). 
 115. § 164.512(i) (regulating “[u]ses and disclosures for research purposes”). 
 116. Is a Business Associate Contract Required for a Covered Entity to Disclose Protected 
Health Information to a Researcher?, U.S. DEP’T HEALTH & HUMAN SERVS. (Dec. 19, 2002), 
http://www.hhs.gov/hipaa/for-professionals/faq/239/is-a-business-associate-contract-required-for-
a-covered-entity-to-information-to-a-researcher/index.html [https://perma.cc/GWD2-2ACD]. 
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reports to HHS, generally for a period of three years, and to pay a fine to HHS. 
These resolution agreements can be very instructive in terms of teaching 
questions that are not specifically answered by the Privacy Rule. 
One question that I frequently encountered in my practice—and about 
which many students have asked over the years as well—is the question 
whether a covered hospital is permitted to allow a film crew to film patients in 
the emergency room in order to produce a reality television show that can 
generate extra revenue for the hospital. Importantly, the camera men would 
obtain the authorization of all filmed patients prior to releasing the final 
television video to a network. As a conservative attorney, I always answered 
my clients and my students in the negative based on my gut, which told me 
that HHS would view this as an unauthorized disclosure of PHI (including the 
patients’ faces and their emergent physical conditions) by the hospital to the 
cameramen, although any subsequent disclosure of the film by the cameramen 
to a television network certainly would be authorized. However, many of my 
less conservative colleagues disagreed. Until recently, neither the Privacy Rule 
nor any HHS guidance provided clear answers. 
On April 19, 2016, however, OCR entered into a resolution agreement 
(“Agreement”) with New York Presbyterian Hospital (“Hospital”) following 
the Hospital’s unauthorized disclosure of two patients’ PHI to an ABC 
television film crew (“ABC”). As background, the Hospital allowed ABC to 
film one patient’s death and a second patient’s significant clinical distress 
without the patients’ or their legal representatives’ prior written authorization 
in violation of the default rule summarized in Part II of this Article117 in order 
to produce the “high stakes medicine” reality television show, NY Med.118 In 
its press release announcing the Agreement, OCR stated, “[The Hospital’s] 
actions blatantly violate the HIPAA Rules, which were specifically designed to 
prohibit the disclosure of individual’s PHI, including images, in circumstances 
such as these.”119 OCR further stated that the Hospital “failed to safeguard 
protected health information and allowed ABC film crews virtually unfettered 
access to its health care facility, effectively creating an environment where PHI 
could not be protected from impermissible disclosure to the ABC film crew 
and staff.”120 In addition to agreeing to pay OCR $2.2 million, the Hospital 
also executed a corrective action plan pursuant to which the Hospital agreed to 
 
 117. See text accompanying supra notes 63–65 for a summary of the default rule. 
 118. About NY Med, ABC, http://abc.go.com/shows/ny-med/about-the-show [https://perma. 
cc/R9AE-4CKJ] (“Sometimes poignant and often uproarious, [NY Med] takes a deep dive into 
high stakes medicine through the eyes of unforgettable characters . . . . ”). 
 119. Unauthorized Filming for “NY Med” Results in $2.2 Million Settlement with New York 
Presbyterian Hospital, U.S. DEP’T HEALTH & HUMAN SERVS. (Apr. 21, 2016), http://www.hhs. 
gov/about/news/2016/04/21/unauthorized-filming-ny-med-results-22-million-settlement-new-
york-presbyterian-hospital.html [https://perma.cc/KJ6G-P8UZ]. 
 120. Id. 
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monitoring by OCR for a period of two years.121 I assigned this resolution 
agreement as reading in my Spring 2017 HIPAA Privacy class. 
C. Teaching Non-Law Audiences 
Parts III (A) and (B), above, discussed methods of teaching the Privacy 
Rule to law students. I am frequently asked to teach physicians, dentists, 
clinical psychologists, social workers, nurses, and other non-law professionals, 
including Privacy officials and compliance officers, regarding their obligations 
under the Privacy Rule. These presentations usually are one or two hours in 
length and the attendees usually receive continuing ethics education (“CE”) 
credit for attending. When I first started providing CEs on the Privacy Rule to 
non-law-trained professionals, I would borrow PowerPoints I had created for 
my law students. These PowerPoints typically included much background 
regarding the Privacy Rule, including references to all the different proposed, 
interim final, and final rulemakings. Being the detailed lawyer that I am, I 
would carefully review the administrative history that led to the regulations 
that are now codified at 45 C.F.R. § 164 and provide a bird’s-eye legal 
overview of the different provisions in the HIPAA and HITECH statutes as 
well as the Privacy Rule, including not only the use-and-disclosure 
requirements, but also the individual rights, the breach notification 
requirements, and the administrative requirements. During the short question-
and-answer session after each presentation, I could tell by the questions that 
the health care professionals were either uninterested in, or simply unable to 
digest, my heavy-in-administrative-law lecture. 
After one presentation that was particularly poorly received, I asked a 
neurology residency program director who attended how I could improve 
going forward. The residency program director said he had an idea; that is, he 
would ask his residents to submit all their Privacy Rule questions to me in 
advance. Then, I could devote my presentation time to the questions in which 
they were interested, rather than the administrative topics in which I was 
interested. We followed this plan shortly thereafter. 
When I received the questions from the residency program director, I 
realized they all focused on the Privacy Rule’s use-and-disclosure 
requirements. I also realized that the questions focused almost exclusively on 
the question whether PHI could be used or disclosed in a particular situation 
with or without prior patient authorization. None of the questions related to the 
 
 121. New York Presbyterian Hospital Resolution Agreement, supra note 37, at 2, § 6 (“HHS 
has agreed to accept, and NYP has agreed to pay HHS, the amount of $2,200,000 . . . . ”); id. at § 
7 (“[The Hospital] has entered into and agrees to comply with the Corrective Action Plan 
(‘CAP’) . . . . If [the Hospital] breaches the CAP, and fails to cure the breach as set forth in the 
CAP, then [the Hospital] will be in breach of this Agreement and HHS will not be subject to the 
Release . . . . ”). 
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administrative history of the Privacy Rule, the personnel designations required 
by the Privacy Rule, the policies and procedures required by the Privacy Rule, 
the compliance dates for the Privacy Rule, or the possible civil and criminal 
penalties for violations of the Privacy Rule. 
I organized the questions I received in order of the use and disclosure 
requirements codified at 45 C.F.R. §§ 164.502–514, with the TPO questions 
early in the presentation and the public benefit disclosures later in the 
presentation. Then, I opened my presentation by reviewing the three use-and-
disclosure rules summarized in Part II of this Article. Finally, I answered each 
question using one of those three rules. By the end of the CE program, the 
physicians who attended understood the three-tiered approach to individual 
permission and were able to answer their own Privacy Rule questions with 
reference to the regulations codified at 45 C.F.R. §§164.502–514. 
CONCLUSION 
This Article has summarized the history of the Privacy Rule, reviewed the 
Privacy Rule’s theory of and approach to health information confidentiality, 
and discussed my experience teaching the Privacy Rule to both law and non-
law audiences. In part because few judicial opinions interpreting the Privacy 
Rule are substantively helpful, this Article suggests that Privacy Rule teachers 
may wish to teach fewer cases and focus instead on the principles of health 
information confidentiality gleaned from the preambles to HHS’s rulemakings 
as well as HHS’s guidance documents, resolution agreements, and frequently 
asked questions. This Article also suggests that Privacy Rule teachers who 
train non-law audiences solicit questions in advance and use these questions to 
illustrate the Privacy Rule’s use-and-disclosure requirements, as bird’s-eye 
legal overviews tend to be unhelpful. 
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